A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity
Dilip K Tosh,Veronica Salmaso,Ryan G Campbell,Harsha Rao,Amelia Bitant,Eline Pottie,Christophe P Stove,Naili Liu,Oksana Gavrilova,Zhan-Guo Gao,John A Auchampach,Kenneth A Jacobson,Dilip K. Tosh,Ryan G. Campbell,Christophe P. Stove,John A. Auchampach,Kenneth A. Jacobson
DOI: https://doi.org/10.1016/j.ejmech.2021.113983
IF: 7.088
2022-01-01
European Journal of Medicinal Chemistry
Abstract:Following our study of 4'-truncated (N)-methanocarba-adenosine derivatives that displayed unusually high mouse (m) A<sub>3</sub>AR affinity, we incorporated dopamine-related N<sup>6</sup> substituents in the full agonist 5'-methylamide series. N<sup>6</sup>-(2-(4-Hydroxy-3-methoxy-phenyl)ethyl) derivative MRS7618 11 displayed K<sub>i</sub> (nM) 0.563 at hA<sub>3</sub>AR (∼20,000-fold selective) and 1.54 at mA<sub>3</sub>AR. 2-Alkyl ethers maintained A<sub>3</sub> affinity, but with less selectivity than 2-alkynes. Parallel functional assays of G protein-dependent and β-arrestin 2 (βarr2)-dependent pathways indicate these are full agonists but not biased. Through use of computational modeling, we hypothesized that phenyl OH/OMe groups interact with polar residues, particularly Gln261, on the mA<sub>3</sub>AR extracellular loops as the basis for the affinity enhancement. Although the pharmacokinetics indicated facile clearance of parent O-methyl catechol nucleosides 21 and 31, prolonged mA<sub>3</sub>AR activation in vivo was observed in a hypothermia model, suggested potential formation of active metabolites through demethylation. Selected analogues induced mouse hypothermia following i.p. injection, indicative of peripheral A<sub>3</sub>AR agonism in vivo.
chemistry, medicinal